At Lonza we always welcome interest and inquiries from the media about our business, services and capabilities. Please use the resources on this page, or contact our media relations team for specific inquiries, and we will connect you to the appropriate business leader or subject matter expert.

08 September 2020
Sheba Medical Center Treats First Patient with CAR-T Cell Immunotherapy...
First cancer patient dosed at Sheba Medical Center, Isreal with autologous CAR-T therapy manufactured using Lonza’s Cocoon® PlatformIsraeli...
30 October 2020
Lonza Announces Agreement to Manufacture AstraZeneca's COVID-19 Long-Acting...
The agreement will provide capacity for the manufacturing of AZD7442, currently being developed for the potential prevention and treatment of...
02 November 2020
Lonza Welcomes New Group Chief Executive Officer Pierre-Alain Ruffieux
Pierre-Alain Ruffieux today commences his role as Chief Executive Officer, following his appointment in June 2020.Albert M. Baehny resumes his role...